Evaluation of the Roche Elecsys Toxo IgG and IgM electrochemiluminescence immunoassay for the detection of gestational Toxoplasma infection

被引:26
|
作者
Prusa, Andrea-Romana [1 ]
Hayde, Michael [1 ]
Unterasinger, Lukas [1 ]
Pollak, Arnold [1 ]
Herkner, Kurt R. [1 ,2 ]
Kasper, David C. [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Paediat & Adolescent Med, A-1090 Vienna, Austria
[2] Med Univ Vienna, Res Core Unit Paediat Biochem & Analyt, A-1090 Vienna, Austria
关键词
Toxoplasma gondu Congenital toxoplasmosis; Gestational infection; Serologic screening; POLYMERASE-CHAIN-REACTION; IMMUNOSORBENT AGGLUTINATION ASSAY; FELDMAN DYE TEST; CONGENITAL TOXOPLASMOSIS; IMMUNOGLOBULIN-G; PREGNANT-WOMEN; PRENATAL TREATMENT; GONDII INFECTION; AMNIOTIC-FLUID; DIAGNOSIS;
D O I
10.1016/j.diagmicrobio.2010.07.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Unidentified gestational infection with Toxoplasma gondu may lead to fetal infection with severe complications later in childhood Because diagnosis of maternal infection solely depends on serology, routine tests with high sensitivity and specificity are required In this study, the new Roche Elecsys Toxo IgG and IgM immunoassay was compared with Sabin-Feldman dye test and immunosorbent agglutination assay-IgM as reference test Serum samples were analyzed from 927 pregnant women, including 100 negative, 706 chronic, and 121 acute infections The combination of both Elecsys IgG and IgM assays demonstrated high sensitivity and specificity of 97 1% and 100 0%, respectively, and a positive and negative predictive value of 100 0% and 81 3%, respectively The Elecsys assay is a useful tool as a first-line screening method to detect gestational infections However, if gestational infection is assumed, confirmatory testing by a reference laboratory might be necessary to discriminate between pre- and postconceptional infection to start antiparasitic treatment to avoid mother-tofetus transmission and severe sequelae (C) 2010 Elsevier Inc All rights reserved
引用
收藏
页码:352 / 357
页数:6
相关论文
共 50 条
  • [21] Performances of ICT Toxoplasma IgG-IgM test in comparison with Vidas® toxo competition to determine the immune status against Toxoplasma gondii
    Sylvie Abraham
    Raphael Piarroux
    Ying Zhou
    Vera Tesic
    Ana Abeleda
    Nadhira Houhou-Fidouh
    Pascale Nicaise-Rolland
    Luce Landraud
    Rima McLeod
    Sandrine Houzé
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2023, 42 : 1327 - 1335
  • [22] Diagnostic performance of the fully automated Roche Elecsys SARS-CoV-2 antigen electrochemiluminescence immunoassay: a pooled analysis
    Lippi, Giuseppe
    Henry, Brandon M.
    Adeli, Khosrow
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2022, 60 (05) : 655 - 661
  • [23] Comparative analysis of the VIDAS Toxo IgG IV assay in the detection of antibodies to Toxoplasma gondii
    Roux-Buisson, N
    Fricker-Hidalgo, H
    Foussadier, A
    Rolland, D
    Suchel-Jambon, AS
    Brenier-Pinchart, MP
    Pelloux, H
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 53 (01) : 79 - 81
  • [24] Performances of ICT Toxoplasma IgG-IgM test in comparison with Vidas® toxo competition to determine the immune status against Toxoplasma gondii
    Abraham, Sylvie
    Piarroux, Raphael
    Zhou, Ying
    Tesic, Vera
    Abeleda, Ana
    Houhou-Fidouh, Nadhira
    Nicaise-Rolland, Pascale
    Landraud, Luce
    Mcleod, Rima
    Houze, Sandrine
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2023, 42 (11) : 1327 - 1335
  • [25] EVALUATION OF AN IGG, IGM, AND IGA FLUORESCENCE IMMUNOASSAY (FIA)
    GENDLER, SM
    KOLLER, A
    LEVIN, SJ
    [J]. CLINICAL CHEMISTRY, 1985, 31 (06) : 925 - 925
  • [26] Preliminary evaluation of Roche Cobas Elecsys Anti-SARS-CoV-2 chemiluminescence immunoassay
    Lippi, Giuseppe
    Salvagno, Gian Luca
    Pegoraro, Manuela
    Militello, Valentina
    Caloi, Cecilia
    Peretti, Angelo
    De Nitto, Simone
    Bovo, Chiara
    Lo Cascio, Giuliana
    [J]. CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (11) : E251 - E253
  • [27] DETECTION OF SPECIFIC IGG AND IGM ANTIBODIES TO TOXOPLASMA-GONDII WITH A COMMERCIALLY AVAILABLE ENZYME-IMMUNOASSAY KIT SYSTEM
    BALFOUR, AH
    HARFORD, JP
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1985, 38 (06) : 679 - 689
  • [28] EVALUATION OF THE FIAX SEMIAUTOMATIC FLUORESCENT IMMUNOASSAY SYSTEM FOR THE DETECTION OF IGG ANTIBODIES TO TOXOPLASMA-GONDII
    CARLSON, LG
    PLORDE, JJ
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1983, 1 (03) : 233 - 239
  • [29] Evaluation of the BioPlex 2200 Lyme IgG/IgM immunoassay system
    Coignard, C.
    Clement-Vincent, C.
    Ly, T.
    L'hotellier, A.
    [J]. CLINICA CHIMICA ACTA, 2019, 493 : S560 - S560
  • [30] Clinical evaluation of new automated cytomegalovirus IgM and IgG assays for the Elecsys® analyser platform
    M. G. Revello
    C. Vauloup-Fellous
    L. Grangeot-Keros
    J. van Helden
    Y. Dickstein
    I. Lipkin
    A. Mühlbacher
    T. Lazzarotto
    [J]. European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 3331 - 3339